LAVAL, QC, March 30, 2021 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) and its gastroenterology
business, Salix Pharmaceuticals ("Salix"), one of the largest
specialty pharmaceutical companies in the world committed to the
prevention and treatment of gastrointestinal diseases, today
announced the launch of a new website, GastroHub for
Advanced Practice Providers (APP), which offers free digital
resources and educational materials for nurse practitioners (NP)
and physician assistants (PA) who treat patients with irritable
bowel syndrome with diarrhea (IBS-D) and hepatic encephalopathy
(HE).
"NPs and PAs have long played a critical role in GI patient
care, and with the increasing rise of telemedicine, there is a need
for educational resources to improve patient care during both
in-person and virtual visits with GI patients," said Robert Spurr, president, Salix.
"GastroHubAPP.com, which was developed in close collaboration with
APPs and features videos, podcasts, patient discussion guides and
symptom questionnaires, aims to aid in the diagnosis of IBS-D and
HE in adults."
GastroHubAPP.com is the third online educational resource
that Salix has created specifically for improving patient care in
the past year, following GutHealthNow.com and
LiverHealthNow.com.
"GastroHubAPP.com offers educational resources designed to
assist in the care of patients with IBS-D and HE, such as
discussion guides that can help patients have more productive
conversations about their symptoms with their health care
providers," said Christina Hanson,
family nurse practitioner at South Denver Gastroenterology, and a
consultant in the development of the website.
About Salix
Salix Pharmaceuticals is one of the
largest specialty pharmaceutical companies in the world committed
to the prevention and treatment of gastrointestinal diseases. For
more than 30 years, Salix has licensed, developed, and marketed
innovative products to improve patients' lives and arm health care
providers with life-changing solutions for many chronic and
debilitating conditions. Salix currently markets its product line
to U.S. health care providers through an expanded sales force that
focuses on gastroenterology, hepatology, pain specialists and
primary care. Salix is headquartered in Bridgewater,
New Jersey. For more information
about Salix, visit www.Salix.com and connect with us
on Twitter and LinkedIn.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Forward-looking Statements
This news release may
contain forward-looking statements, which may generally be
identified by the use of the words "anticipates," "expects,"
"intends," "plans," "should," "could," "would," "may," "believes,"
"estimates," "potential," "target," or "continue" and variations or
similar expressions. These statements are based upon the current
expectations and beliefs of management and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include, but are not limited to, the
risks and uncertainties discussed in the Bausch Health's most
recent annual report on Form 10-K and detailed from time to time in
Bausch Health's other filings with the U.S. Securities and Exchange
Commission and the Canadian Securities Administrators, which
factors are incorporated herein by reference. They also include,
but are not limited to, risks and uncertainties caused by or
relating to the evolving COVID-19 pandemic, and the fear of that
pandemic and its potential effects, the severity, duration and
future impact of which are highly uncertain and cannot be
predicted, and which may have a material adverse impact on Bausch
Health, including but not limited to its project development
timelines, and costs (which may increase). Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch Health undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
SAL.0052.USA.21
©2021 Salix Pharmaceuticals or its
affiliates.
Investor
Contact:
|
Media
Contacts:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/salix-launches-gastrohub-for-advanced-practice-providers-an-educational-website-designed-to-provide-nurse-practitioners-and-physician-assistants-with-relevant-information-for-treating-ibs-d-and-he-301258533.html
SOURCE Bausch Health Companies Inc.